Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.
Sharib J, Rhodin KE, Liu A, McIntyre S, Bartholomew A, Masoud S, DeLaura I, Kemeny NE, Cercek A, Harding JJ, O'Reilly EM, Abou-Alfa GK, Reidy-Lagunes D, Connell LC, Dika IE, Balachandran VP, Drebin J, Soares KC, Wei AC, Kingham TP, D'Angelica MI, Uronis H, Strickler J, Hsu SD, Morse M, Zani S, Allen PJ, Jarnagin WR, Lidsky ME. Sharib J, et al. Among authors: uronis h. Ann Surg Oncol. 2025 Jan 18. doi: 10.1245/s10434-024-16799-0. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39827317
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responses.
Nixon AB, Navarro FCP, Zhou KI, Abbott C, McDaniel L, Howard L, Brady JC, Liu Y, Jia J, Niedzwiecki D, Strickler J, Boyle SM, Chen RO, Uronis H. Nixon AB, et al. Among authors: uronis h. Res Sq [Preprint]. 2024 Dec 18:rs.3.rs-5349536. doi: 10.21203/rs.3.rs-5349536/v1. Res Sq. 2024. PMID: 39764133 Free PMC article. Preprint.
ASO Visual Abstract: Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding Hai Program.
Liu A, Lowe M, Niedzwiecki D, Rhodin KE, Sharib J, Wildman-Tobriner B, Wong TZ, Kim CY, Thacker J, Mantyh C, Migaly J, Lan BY, Strickler JH, Hsu SD, Nussbaum D, Zani S, Uronis H, Allen PJ, Lidsky ME. Liu A, et al. Among authors: uronis h. Ann Surg Oncol. 2025 Jan 2. doi: 10.1245/s10434-024-16611-z. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39743650 No abstract available.
Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program.
Liu A, Lowe M, Niedzwiecki D, Rhodin KE, Sharib J, Wildman-Tobriner B, Wong TZ, Kim CY, Thacker J, Mantyh C, Migaly J, Lan BY, Strickler JH, David Hsu S, Nussbaum D, Zani S, Uronis H, Allen PJ, Lidsky ME. Liu A, et al. Among authors: uronis h. Ann Surg Oncol. 2025 Feb;32(2):1033-1042. doi: 10.1245/s10434-024-16488-y. Epub 2024 Nov 20. Ann Surg Oncol. 2025. PMID: 39565488
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish.
Klempner SJ, Sonbol MB, Wainberg ZA, Uronis HE, Chiu VK, Scott AJ, Iqbal S, Tejani MA, Chung V, Stilian MC, Thoma M, Zhang Y, Kagey MH, Baum J, Sirard CA, Altura RA, Ajani JA. Klempner SJ, et al. Among authors: uronis he. J Clin Oncol. 2025 Jan 20;43(3):339-349. doi: 10.1200/JCO.24.00410. Epub 2024 Oct 21. J Clin Oncol. 2025. PMID: 39432867 Clinical Trial.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Oh DY, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H. Catenacci DV, et al. Among authors: uronis he. Oncology (Williston Park). 2023 Apr 25;37(4):176-183. doi: 10.46883/2023.25920992. Oncology (Williston Park). 2023. PMID: 37104758 Free article.
mHealth Coping Skills Training for Symptom Management (mCOPE) for colorectal cancer patients in early to mid-adulthood: Study protocol for a randomized controlled trial.
Hyland KA, Amaden GH, Diachina AK, Miller SN, Dorfman CS, Berchuck SI, Winger JG, Somers TJ, Keefe FJ, Uronis HE, Kelleher SA. Hyland KA, et al. Among authors: uronis he. Contemp Clin Trials Commun. 2023 Apr 5;33:101126. doi: 10.1016/j.conctc.2023.101126. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 37077935 Free PMC article.
64 results